As the year comes to a close it is important for investors to perhaps look into some stocks which have performed well in 2021 so far. One such stock is that of Predictive Oncology (NASDAQ:POAI), a company that is involved in deploying artificial intelligence into the drug discovery and predictive medicine spaces.
Trading Data
On Monday, POAI stock slid 2.60% to $0.9840 with more than 309k shares, compared to its average volume of 1.19 million shares. The stock has moved within a range of $0.9820 – 1.0400 after opening trade at $1.04.
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
The stock has managed to clock gains of as much as 37% this year so far and hence, it may be a good move to take a look at the announcement made by Predictive Oncology yesterday. Predictive Oncology announced yesterday that back on December 23, 2021, the Annual Meeting of Shareholders had been convened at 3 p.m. Central Time.
However, the meeting had to be adjourned straightaway since there was no quorum. The reason why the company was no table to achieve a quorum at the meeting was due to the fact that most of the people present at the meeting in person or by proxy were not eligible for a vote. The meeting is going to be held again later on this week on December 30, 2021 at 3 in the afternoon Central Time. Investors could do well to keep an eye on the proceedings.
Technical Data
POAI stock is trading below the 20-Day and 50-Day Moving averages of $1.01 and $1.11 respectively. Moreover, the stock is trading below the 200-Day moving average of $1.15. The stock is down 8% in the past week.
